HLS Therapeutics (74D.F) Q4 2024 Earnings

Nov 7Confirmed
Q2 2024
Q3 2024
Q4 2024
-0.18
-0.16
-0.14
-0.12

Details

Expected EPS
-0.11561052375
Actual EPS
-0.1388715
Surprise EPS
-0.02
Surprise Percent
-20.12%

Description

⁨HLS Therapeutics⁩ (⁦74D.F⁩) has reported earnings of ⁦-0.1388715⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts